Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Revertant Phenomenon in DMD and LGMD2I and Its Therapeutic Implications: A Review of Study Under Mentorship of Terrence Partridge.

Journal of neuromuscular diseases - 1 Jan 2021

Lu Qi Long

Abstract excerpt

This review recollects my initial research focus on revertant fibers (expressing dystrophin in the background of frame-shifting mutation) in Duchenne muscular dystrophy (DMD) muscles in Professor Terrence Partridge's Muscle Cell Biology Laboratory in MRC Clinical Research Science Center, Harmmersmith Hospital, London, UK. Our data indicated that revertant fibers are most likely resulted from epigenetic random...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Exons
Share to Genetic Therapy
Share to Mice

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Muscle Fibers, Skeletal

Share to Muscular Dystrophies, Limb-Girdle

Share to Muscular Dystrophy, Duchenne

Share to Mutation

Share to Pentosyltransferases

Source

Open in PubMed Open full text

Identifiers

PMID: 34151854
DOI: 10.3233/JND-210692
PMCID: PMC8673541

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Revertant Phenomenon in DMD and LGMD2I and Its Therapeutic Implications: A Review of Study Under Mentorship of Terrence Partridge.PMID 34151854Read ↗

Revertant fibres: a possible genetic therapy for Duchenne muscular dystrophy?Semantic proximity Read ↗

Redirecting splicing to address dystrophin mutations: molecular by-pass surgery.Semantic proximity Read ↗

NAD+ enhances ribitol and ribose rescue of α-dystroglycan functional glycosylation in human FKRP-mutant myotubes.Semantic proximity Read ↗

Mechanisms of natural gene therapy in dystrophic epidermolysis bullosa.Semantic proximity Read ↗

Revertant mosaicism in genodermatoses.Semantic proximity Read ↗

Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping.Semantic proximity Read ↗

Duchenne Muscular Dystrophy Myogenic Cells from Urine-Derived Stem Cells Recapitulate the Dystrophin Genotype and Phenotype.Semantic proximity Read ↗

Abnormal splicing switch of DMD’s penultimate exon compromises muscle fibre maintenance in myotonic dystrophySemantic proximity Read ↗

Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients.Semantic proximity Read ↗

Read-through approach for stop mutations in Duchenne muscular dystrophy. An update.Semantic proximity Read ↗

Therapeutic exon skipping for dysferlinopathies?Semantic proximity Read ↗

Reverse mosaicism in Fanconi anemia: natural gene therapy via molecular self-correction.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.